JP2007500196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500196A5 JP2007500196A5 JP2006529900A JP2006529900A JP2007500196A5 JP 2007500196 A5 JP2007500196 A5 JP 2007500196A5 JP 2006529900 A JP2006529900 A JP 2006529900A JP 2006529900 A JP2006529900 A JP 2006529900A JP 2007500196 A5 JP2007500196 A5 JP 2007500196A5
- Authority
- JP
- Japan
- Prior art keywords
- skin
- vivo
- preparation according
- preparation
- hcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 claims 18
- 210000003491 Skin Anatomy 0.000 claims 10
- 239000000839 emulsion Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 238000004321 preservation Methods 0.000 claims 4
- 210000002510 Keratinocytes Anatomy 0.000 claims 3
- 210000004927 Skin cells Anatomy 0.000 claims 3
- 210000002950 fibroblast Anatomy 0.000 claims 3
- 239000006260 foam Substances 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 239000002609 media Substances 0.000 claims 3
- 239000011505 plaster Substances 0.000 claims 3
- 239000003104 tissue culture media Substances 0.000 claims 3
- 229920001661 Chitosan Polymers 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N DEOXYTHYMIDINE Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims 2
- 229960002743 Glutamine Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- 210000002966 Serum Anatomy 0.000 claims 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M Sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 239000006143 cell culture media Substances 0.000 claims 2
- 210000004027 cells Anatomy 0.000 claims 2
- 229960005188 collagen Drugs 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- IFQSXNOEEPCSLW-DKWTVANSSA-N (2R)-2-amino-3-sulfanylpropanoic acid;hydron;chloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 claims 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 claims 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims 1
- 229960003767 Alanine Drugs 0.000 claims 1
- 229960001230 Asparagine Drugs 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- 229960003178 Choline Chloride Drugs 0.000 claims 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M Choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims 1
- 235000019743 Choline chloride Nutrition 0.000 claims 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N Chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 208000008313 Contusions Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims 1
- 229960000304 Folic Acid Drugs 0.000 claims 1
- 229960001031 Glucose Drugs 0.000 claims 1
- 229960002989 Glutamic Acid Drugs 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 210000004209 Hair Anatomy 0.000 claims 1
- 229960000310 ISOLEUCINE Drugs 0.000 claims 1
- 229960000367 Inositol Drugs 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N Inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-UWTATZPHSA-N L-Asparagine Natural products OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 1
- 235000019766 L-Lysine Nutrition 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 235000014852 L-arginine Nutrition 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 239000004395 L-leucine Substances 0.000 claims 1
- 235000019454 L-leucine Nutrition 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- 208000005230 Leg Ulcer Diseases 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 210000002752 Melanocytes Anatomy 0.000 claims 1
- 229960004452 Methionine Drugs 0.000 claims 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 1
- 101710012892 PIGK Proteins 0.000 claims 1
- 229960005190 Phenylalanine Drugs 0.000 claims 1
- 229960002429 Proline Drugs 0.000 claims 1
- 229960002477 Riboflavin Drugs 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 claims 1
- 210000004761 Scalp Anatomy 0.000 claims 1
- 229940054269 Sodium Pyruvate Drugs 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 229940104230 Thymidine Drugs 0.000 claims 1
- 229960004441 Tyrosine Drugs 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 1
- 229960002079 calcium pantothenate Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000003346 cobalamin group Chemical group 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 239000008406 cosmetic ingredient Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 210000002865 immune cell Anatomy 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229960003136 leucine Drugs 0.000 claims 1
- 235000019136 lipoic acid Nutrition 0.000 claims 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 1
- 229960003646 lysine Drugs 0.000 claims 1
- -1 mask Substances 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 230000003204 osmotic Effects 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 229960002862 pyridoxine Drugs 0.000 claims 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
- 235000019192 riboflavin Nutrition 0.000 claims 1
- 239000002151 riboflavin Substances 0.000 claims 1
- 229960001153 serine Drugs 0.000 claims 1
- 230000036560 skin regeneration Effects 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 229960002663 thioctic acid Drugs 0.000 claims 1
- 229960002898 threonine Drugs 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (15)
- 1種もしくはそれ以上の組織培養培地、特に皮膚細胞培養培地を含んでなる化粧用および/もしくは皮膚科学的調製物。
- 組織培養培地が、mg/l単位の濃度範囲内で以下の成分:
ビオチン 0.0036 0.0146
CaCl2.2H2O 4.41 116.61
パントテン酸カルシウム 0.25 2.24
塩化コリン 9 13.96
CuSO4.5H2O 0.0002496 0.00125
D-グルコース 1081 3151
FeSO4.7H2O 0.417 1.39
葉酸 0.79 2.65
グリシン 7.51 18.75
イノシトール 12.6 18.02
KCl 111.83 311.8
L-アラニン 4.5 8.91
L-アルギニン.HCl 147.5 210.7
L-アスパラギン 7.5 15.01
L-アスパラギン酸 3.99 6.65
L-システイン.HCl 15.75 42.04
L-グルタミン 365.3 877.2
L-グルタミン酸 7.35 14.71
L-ヒスチジン.HCl.H2O 16.77 31.5
リポ酸 0.11 0.2063
L-イソロイシン 1.968 54.5
L-ロイシン 59 65.6
L-リシン.HCl 18.27 91.25
L-メチオニン 4.475 17.24
L-フェニルアラニン 4.956 35.5
L-プロリン 17.25 34.53
L-セリン 26.25 63.06
L-トレオニン 11.91 53.5
L-チロシン 2.718 38.7
L-バリン 35.13 52.85
MgCl2.6H2O 61 122
Na2HPO4.7H2O 71 536.2
NaCl 6999.5 7599
NaHCO3 1176 2438
ピルビン酸ナトリウム 47 63
ニコチンアミド 0.03663 2.02
ピリドキシンHCl 0.031 0.06171
リボフラビン 0.03764 0.22
チアミンHCl 0.3373 2.17
チミジン 0.37 0.7266
ビタミンB12(コバラミン) 0.68 4.07
を含んでなることを特徴とする請求項1に記載の調製物。 - 培地がDMEM/ハムF−12(1:1)および/もしくはMCDB153から選択されることを特徴とする請求項1に記載の調製物。
- 培地が血清を含まないことを特徴とする請求項1、2もしくは3に記載の調製物。
- コラーゲン、50%までのアセチル化度を有するキトサンおよびグリコシルアミノグリカンを含んでなる混合物が添加されることを特徴とする請求項1、2もしくは3に記載の調製物。
- 血清代用品、特にキトサン、コンドロイチン−6−硫酸、コラーゲンもしくはそれらの混合物、または植物皮膚機能性誘導剤が添加されることを特徴とする請求項1、2、3もしくは5に記載の調製物。
- 調製物が水性もしくは水性−アルコール性溶液、スプレー、フォーム、フォームエアロゾル、軟膏、水性ゲル、O/W、W/OもしくはW/O/Wタイプのエマルジョン、マイクロエマルジョンまたは化粧用スティック調製物であることを特徴とする請求項1〜6の1つに記載の調製物。
- グルタミンが培地に添加されることを特徴とする請求項1〜7の1つに記載の調製物。
- 水性界面活性剤調製物、エマルジョン、軟膏もしくはクリーム、ゲル、パウダー、マスク、マトリックス硬膏、ゲル硬膏、フォームまたはエアロゾル調製物の形態の皮膚、頭皮へのもしくは毛髪への局所使用のための請求項1〜8の1つに記載の調製物の使用。
- エマルジョンがO/Wエマルジョンであるかもしくはマトリックス硬膏がポリウレタンマトリックスであることを特徴とする請求項9に記載の使用。
- 無水の適用形態としての、特にスポンジもしくはパウダーの形態の請求項1〜8の1つに記載の調製物の使用。
- 組織培養培地を使用直前まで調製物の他の化粧用成分と混合しないことを特徴とする請求項1〜8の1つに記載の調製物の使用。
- 無機もしくは有機バイオファクターにおける細胞培養培地の成分の比率が、それらがインビトロ、エクスビボおよびインビボにおける皮膚細胞の保存、培養およびケアに適当であるように選択されることを特徴とする請求項1〜8の1つに記載の調製物の使用。
- 代用品が浸透圧調節剤として用いられることを特徴とする請求項5もしくは6に記載の調製物の使用。
- a.繊維芽細胞、ケラチノサイト細胞、ケラチノサイトと繊維芽細胞との共培養物、繊維芽細胞/ケラチノサイトと免疫細胞、メラニン細胞のような他の皮膚関連細胞との共培養物のインビトロ、エクスビボおよび/もしくはインビボにおける培養のため、保持のためもしくはケアのための、
b.3次元皮膚モデルの作製のための、
c.免疫応答性3次元皮膚モデルの作製のための、
d.特に熱傷の処置のための、特に残存する皮膚細胞の新規培養のための、インビトロ、エクスビボおよびインビボにおける正常ヒト皮膚の保存のためのもしくはケアのための、
e.適宜皮膚の罹患領域の切除後の、特に皮膚の再生のための、インビトロ、エクスビボおよびインビボにおける罹患したヒト皮膚の保存のためのもしくはケアのための、および/または
f.特に下腿潰瘍、打撲傷および熱傷の場合に残存する細胞からの皮膚の再生のための、インビトロ、エクスビボおよびインビボにおける損傷を受けたヒト皮膚の保存のためのもしくはケアのための
請求項1〜8の1つに記載の調製物の使用。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10323510 | 2003-05-24 | ||
DE10355110 | 2003-11-24 | ||
DE102004020035 | 2004-04-22 | ||
PCT/EP2004/005532 WO2004103333A1 (de) | 2003-05-24 | 2004-05-22 | Gewebekulturmedien als bestandteil von kosmetika |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007500196A JP2007500196A (ja) | 2007-01-11 |
JP2007500196A5 true JP2007500196A5 (ja) | 2007-07-12 |
Family
ID=33479380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006529900A Pending JP2007500196A (ja) | 2003-05-24 | 2004-05-22 | 化粧品の成分として使用される組織培養培地 |
Country Status (4)
Country | Link |
---|---|
US (3) | US20050249691A1 (ja) |
EP (3) | EP1635782A1 (ja) |
JP (1) | JP2007500196A (ja) |
WO (1) | WO2004103333A1 (ja) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1635782A1 (de) * | 2003-05-24 | 2006-03-22 | JUVENA (International) AG | Gewebekulturmedien als bestandteil von kosmetika |
KR101374448B1 (ko) * | 2005-05-13 | 2014-03-17 | 야이즈 스이산가가쿠 고교 가부시키가이샤 | 피부 재생을 촉진하는 의료용 조성물 |
TR201809592T4 (tr) * | 2006-02-06 | 2018-07-23 | Dsm Ip Assets Bv | Aktif içerik maddelerinin bileşimleri. |
ITMI20061219A1 (it) * | 2006-06-23 | 2007-12-24 | Flamma Spa | Composti dipeptidici contenenti d-istidina |
JPWO2008096547A1 (ja) * | 2007-02-07 | 2010-05-20 | 焼津水産化学工業株式会社 | 組織滞留性キトサンゲルを含有する抗腫瘍剤組成物 |
FR2912916B1 (fr) | 2007-02-26 | 2009-05-22 | Oreal | Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire |
FR2912917B1 (fr) | 2007-02-26 | 2012-05-18 | Oreal | Milieu conditionne et ses utilisations |
WO2009002913A1 (en) * | 2007-06-22 | 2008-12-31 | Avicena Group, Inc. | Use of creatine compounds to treat dermatitis |
US20090131537A1 (en) * | 2007-11-14 | 2009-05-21 | Wille Jr John Jacob | Wound healing compositions |
CL2008000156A1 (es) * | 2008-01-18 | 2008-08-01 | Igloo Zone Chile S A | Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel. |
US8372821B2 (en) * | 2008-04-09 | 2013-02-12 | Jack H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
US9610463B2 (en) | 2009-01-30 | 2017-04-04 | Beiersdorf Ag | Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex |
DE102010004478A1 (de) * | 2010-01-12 | 2011-07-14 | Riesinger, Birgit, 48346 | Neue Technologien zur Verwendung in Wundauflagen mit superabsorbierenden Polymeren |
US9999702B2 (en) | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
WO2012069073A1 (de) * | 2010-11-12 | 2012-05-31 | La Prairie Group Ag | Kosmetische und/oder dermatologische zubereitungen enthaltend schneealgenextrakt |
CN102688483B (zh) | 2011-03-22 | 2015-02-18 | 王成德 | 一种治疗皮肤病的组合物、含有该组合物的制剂及其制备方法 |
TWI491414B (zh) * | 2011-05-25 | 2015-07-11 | Taiwan Textile Res Inst | 具有提示功能之皮膚護理產品及其使用方法 |
US8945637B2 (en) * | 2012-10-02 | 2015-02-03 | Aloe Bioscience, Llc | Decubitus treatment system |
US9907745B2 (en) | 2014-01-15 | 2018-03-06 | Serucell Corporation | Cosmetic compositions and method of making the same |
US10533191B2 (en) | 2014-01-15 | 2020-01-14 | Serucell Corporation | Therapeutic serum obtained from co-cultured cells |
US9974813B1 (en) | 2014-01-15 | 2018-05-22 | Serucell Corporation | Therapeutic serum obtained from co-cultured cells |
US20170239286A1 (en) * | 2014-06-11 | 2017-08-24 | International Scientific Pty Ltd. | Device and method to treat or prevent joint degeneration |
WO2015199753A1 (en) * | 2014-06-23 | 2015-12-30 | Sand Bruce J | Restoration of pre-mature aging skin |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
CN104352428A (zh) * | 2014-10-08 | 2015-02-18 | 徐炎 | 一种保护乳酸菌和养护阴道细胞的妇女阴道膏 |
KR20170110083A (ko) | 2014-12-23 | 2017-10-10 | 인털렉츄얼 프라퍼티 어쏘시에이츠, 엘엘씨 | 경피 투여를 위한 방법 및 제형 |
CN109071750B (zh) | 2016-03-08 | 2022-08-02 | 生活实验公司 | 持久化妆品组合物 |
WO2017165281A1 (en) | 2016-03-22 | 2017-09-28 | Avicenna Nutraceutical, Llc | Hydrolyzed collagen compositions and methods of making thereof |
CN109195579B (zh) * | 2016-04-01 | 2022-09-16 | 韩国比奥科斯全球公司 | 包含在细胞培养基中的白蛋白、透明质酸或胶原蛋白作为活性成分的化妆品组合物 |
KR101809209B1 (ko) * | 2016-05-31 | 2017-12-15 | 주식회사 올리패스코스메슈티컬즈 | 두피의 건강 개선을 위한 화장료 조성물 및 이의 제조방법 |
JP2018123118A (ja) * | 2016-11-30 | 2018-08-09 | 上野製薬株式会社 | 皮膚の老化抑制剤 |
WO2019055445A2 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | COLOR PROTECTION COMPOSITIONS |
CA3074843A1 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | Long lasting cosmetic compositions |
US11766391B2 (en) | 2018-05-22 | 2023-09-26 | HSP Technologies LLC | Hair care compositions and methods of making and using same |
KR102216302B1 (ko) * | 2018-09-21 | 2021-02-17 | 메디포스트(주) | 피부 세포 활성화용 조성물 및 이의 용도 |
JP2020152717A (ja) * | 2019-03-12 | 2020-09-24 | 株式会社ナノエッグ | 敏感肌用化粧水 |
US11065188B2 (en) * | 2019-05-29 | 2021-07-20 | Av Laboratories Llc | Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents |
US11737997B2 (en) * | 2019-06-28 | 2023-08-29 | Merck Patent Gmbh | Method to increase cellular availability of calcium in skin cells and mixtures |
EP4001296A1 (de) | 2020-11-20 | 2022-05-25 | Eberhard Karls Universität Tübingen | Neue zyklische verbindungen, verfahren zu deren herstellung und die verwendung dieser zyklischen verbindungen in kosmetischen zubereitungen |
CN112353756B (zh) * | 2020-12-02 | 2022-06-14 | 武汉大学 | 一种具有微孔结构的医用缓释凝胶的制备方法及治疗皮炎和湿疹的冷敷凝胶 |
WO2023158505A1 (en) * | 2022-02-16 | 2023-08-24 | Prothione Llc | Compositions and methods for the treatment of human immunodeficiency virus |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US100588A (en) * | 1870-03-08 | Improved paint compoottd | ||
US166579A (en) * | 1875-08-10 | Improvement in washing-machines | ||
US67584A (en) * | 1867-08-06 | reynolds | ||
US155603A (en) * | 1874-10-06 | Improvement in wire fences | ||
US4414202A (en) * | 1980-02-19 | 1983-11-08 | Silvetti Anthony N | Composition for treatment of wounds |
LU83350A1 (fr) * | 1981-05-08 | 1983-03-24 | Oreal | Composition destinee au traitement des fibres keratiniques a base de polymere cationique et de polymere anionique a groupements vinylsulfoniques et procede de traitement la mettant en oeuvre |
US4778679A (en) * | 1981-09-14 | 1988-10-18 | Silvetti Anthony N | Method and composition for treatment of wounds |
US4605623A (en) * | 1982-11-08 | 1986-08-12 | Malette William Graham | Method of altering growth and development and suppressing contamination microorganisms in cell or tissue culture |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
FR2580275B1 (fr) * | 1985-04-16 | 1988-11-18 | Nouvel Colette | Perfectionnement a la preparation et applications de bisphenols substitues |
JPS61253065A (ja) * | 1985-05-02 | 1986-11-10 | 片倉チツカリン株式会社 | キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法 |
FR2585567B1 (fr) * | 1985-08-01 | 1988-09-16 | Seguin Marie Christine | Nouvelle composition cosmetique issue de cultures cellulaires de tissu conjonctif |
US4619827A (en) * | 1985-10-07 | 1986-10-28 | Neogen Corporation | Method for administering equine vaccines and compositions therefor |
US4647795A (en) | 1986-03-28 | 1987-03-03 | Tektronix, Inc. | Travelling wave sampler |
FR2616318A1 (fr) * | 1987-06-15 | 1988-12-16 | Centre Nat Rech Scient | Peau artificielle et son procede de preparation |
JPS642643A (en) * | 1987-06-26 | 1989-01-06 | Bio Material Yunibaasu:Kk | Artificial skin |
JP2662737B2 (ja) | 1988-09-30 | 1997-10-15 | アイシン精機株式会社 | ドアロツク装置 |
JPH06104116B2 (ja) * | 1988-11-29 | 1994-12-21 | 三菱化成株式会社 | 創傷被覆材 |
US5106949A (en) * | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
IT1248934B (it) * | 1990-06-01 | 1995-02-11 | Fidia Spa | Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle |
US5652274A (en) * | 1991-03-01 | 1997-07-29 | Martin; Alain | Therapeutic-wound healing compositions and methods for preparing and using same |
EP0513803A2 (en) * | 1991-05-17 | 1992-11-19 | Japan Vilene Company, Ltd. | Carrier for immobilization of animal cells, process for manufacture thereof, and methods for cultivation |
HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
GB9206508D0 (en) * | 1992-03-25 | 1992-05-06 | Jevco Ltd | Biopolymer composites |
GB9210574D0 (en) * | 1992-05-18 | 1992-07-01 | Ca Nat Research Council | Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications |
DE4308347A1 (de) | 1993-03-17 | 1994-09-29 | Beiersdorf Ag | Hydrophile Polyurethanschaumgele, insbesondere zur Behandlung von tiefen Wunden und Verfahren zu deren Herstellung |
DE4233289A1 (de) | 1992-10-02 | 1994-04-07 | Beiersdorf Ag | Hydrophile Polyurethanschaumgele und Verfahren zu deren Herstellung |
DE4308445A1 (de) | 1993-03-17 | 1994-09-22 | Beiersdorf Ag | Wundverbände auf Basis hydrophiler Polyurethangelschäume und Verfahren zu deren Herstellung |
AU692424B2 (en) * | 1992-10-02 | 1998-06-11 | Beiersdorf Aktiengesellschaft | Hydrophilic polyurethane gel foams, particularly for treating deep wounds, wound dressing based on hydrophilic polyurethane gel foams and method of manufacture |
GB2272645B8 (en) * | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
FR2699080B1 (fr) * | 1992-12-11 | 1995-04-07 | Lvmh Rech | Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue. |
US5534416A (en) * | 1993-04-13 | 1996-07-09 | Molecular Probes, Inc. | Fluorescent viability assay using cyclic-substituted unsymmetrical cyanine dyes |
DE4328190A1 (de) | 1993-08-23 | 1995-03-02 | Beiersdorf Ag | Wundversorgungsartikel mit selektivem Absorptionsvermögen |
US5622834A (en) * | 1993-12-01 | 1997-04-22 | Marine Polymer Technologies, Inc. | Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture |
AU1060495A (en) * | 1993-12-01 | 1995-06-19 | Universite Du Quebec A Montreal | Albumin based hydrogel |
US5489304A (en) * | 1994-04-19 | 1996-02-06 | Brigham & Women's Hospital | Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft |
DE19504398A1 (de) * | 1995-02-10 | 1996-08-14 | Beiersdorf Ag | Tocopherylglycoside, ihre Herstellung sowie ihre Verwendung als Tenside, als Antioxidantien sowie als der Zellalterung vorbeugender Wirkstoff in kosmetischen oder pharmazeutischen Zubereitungen |
JP3543869B2 (ja) * | 1995-03-07 | 2004-07-21 | 株式会社メニコン | 培養皮膚およびその製造法 |
US6262255B1 (en) * | 1995-04-05 | 2001-07-17 | Biomm, Inc. | Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them |
US5612040A (en) * | 1995-04-07 | 1997-03-18 | The United States Of America As Represented By The Secretary Of Agriculture | Non-infectious foot-and-mouth disease viruses |
WO1996041818A1 (en) * | 1995-06-09 | 1996-12-27 | Drohan William N | Chitin hydrogels, methods of their production and use |
US6043092A (en) * | 1996-03-18 | 2000-03-28 | University Of Pittsburgh | Cell culture media for mammalian cells |
JP3638614B2 (ja) * | 1996-07-25 | 2005-04-13 | ジェンザイム・コーポレーション | 軟骨細胞培地組成および培養方法 |
US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
US6756060B1 (en) * | 1996-09-19 | 2004-06-29 | Usbiomaterials Corp. | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
US5948385A (en) * | 1996-09-30 | 1999-09-07 | Baxter International Inc. | Antimicrobial materials |
US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
EP0939797B1 (en) | 1996-10-11 | 2007-03-07 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
WO1998022114A1 (en) | 1996-11-15 | 1998-05-28 | Dumex-Alpharma A/S | A method for promoting tissue repair |
US5968528A (en) * | 1997-05-23 | 1999-10-19 | The Procter & Gamble Company | Skin care compositions |
US6432710B1 (en) * | 1998-05-22 | 2002-08-13 | Isolagen Technologies, Inc. | Compositions for regenerating tissue that has deteriorated, and methods for using such compositions |
AU4933099A (en) * | 1998-07-31 | 2000-02-21 | Seikagaku Corporation | Novel glycosaminoglycan and drug compositions containing the same |
EP1123072B1 (en) * | 1998-09-10 | 2014-05-14 | Schott Ag | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
GB9914616D0 (en) * | 1999-06-23 | 1999-08-25 | Univ Sheffield | Attachment surface |
US6746481B1 (en) * | 1999-06-28 | 2004-06-08 | Medtronic, Inc. | Implatable device including a polyamino acid component |
US6231836B1 (en) * | 1999-07-12 | 2001-05-15 | Robert Takhtalian | Folic acid dentifrice |
GB9917180D0 (en) * | 1999-07-23 | 1999-09-22 | Univ Sheffield | Cell surface receptor |
DE19959750C1 (de) * | 1999-12-11 | 2001-05-31 | Axel Thierauf | Verfahren zur Herstellung eines Hautimplantats, insbesondere Eigenhaut-Implantat und nach dem Verfahren hergestelltes Implantat |
WO2001042789A1 (en) * | 1999-12-13 | 2001-06-14 | The Scripps Research Institute | MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
US6974679B2 (en) * | 2000-05-26 | 2005-12-13 | Coletica | Support with collagen base for tissue engineering and manufacture of biomaterials |
FR2809412A1 (fr) * | 2000-05-26 | 2001-11-30 | Coletica | Utilisation de collagene d'origine aquatique pour la realisation de supports destines a l'ingenierie tissulaire, et supports et biomateriaux obtenus |
US6790454B1 (en) * | 2000-05-26 | 2004-09-14 | Coletica | Processes for the preparation of novel collagen-based supports for tissue engineering, and biomaterials obtained |
US20040028738A1 (en) * | 2000-10-05 | 2004-02-12 | Lynn L.H. Huang | Process for the preparation of porous collagen matrix |
EP1404809B1 (en) * | 2001-03-02 | 2013-12-11 | Stratatech Corporation | Improved skin substitutes and uses thereof |
US6500476B1 (en) * | 2001-03-28 | 2002-12-31 | Epl Technologies, Inc. | Preservation compositions and process for mushrooms |
US20050100588A1 (en) * | 2001-06-13 | 2005-05-12 | Beiersdorf Ag | Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels |
DE10128685A1 (de) | 2001-06-13 | 2002-12-19 | Beiersdorf Ag | Selbstklebendes, wirkstoffhaltiges Matrixpflaster auf Basis von Polyurethangelen |
JP3805654B2 (ja) | 2001-08-29 | 2006-08-02 | 株式会社ネクスト | 止血・癒着防止性のバイオポリマーの微細粒子 |
US20040153040A1 (en) * | 2003-02-05 | 2004-08-05 | Lucie Martineau | Multi-layer synthetic dressing with cooling characteristics |
EP1635782A1 (de) * | 2003-05-24 | 2006-03-22 | JUVENA (International) AG | Gewebekulturmedien als bestandteil von kosmetika |
-
2004
- 2004-05-22 EP EP04734472A patent/EP1635782A1/de not_active Ceased
- 2004-05-22 WO PCT/EP2004/005532 patent/WO2004103333A1/de active Application Filing
- 2004-05-22 JP JP2006529900A patent/JP2007500196A/ja active Pending
- 2004-05-22 EP EP04078585.9A patent/EP2340856B2/de not_active Expired - Lifetime
- 2004-05-22 EP EP04734469A patent/EP1896092A1/de active Pending
- 2004-10-19 US US10/967,232 patent/US20050249691A1/en not_active Abandoned
-
2005
- 2005-03-01 US US11/068,052 patent/US8518422B2/en active Active
- 2005-11-23 US US11/285,342 patent/US8507276B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007500196A5 (ja) | ||
CN107106459B (zh) | 包含细胞培养基、表皮生长因子和牛血清白蛋白的用于改善皮肤状态的药物组合物 | |
JP3859708B2 (ja) | 表皮細胞用の培養培地として使用される栄養培地と適用 | |
US8518422B2 (en) | Cosmetic or dermatological preparation comprising a nutrient medium phase | |
KR101294245B1 (ko) | 5-아미노레블린산 및 실크펩타이드를 함유하는 손상된 모발용 트리트먼트 조성물 및 그 제조방법 | |
EP1609462B1 (en) | Cosmetic or dermatological preparation comprising a nutrient medium phase | |
ES2681211T3 (es) | Composiciones inyectables de uso intraarticular que asocian un agente de viscosuplementación y un medio de crecimiento de fibroblastos | |
KR20120089433A (ko) | 충전제와 섬유아세포 성장 배지를 조합한 주사용 조성물 | |
KR102368465B1 (ko) | 세포배양배지에 알부민, 히알루론산, 또는 콜라겐을 유효성분으로 포함하는 화장용 조성물 | |
IS7908A (is) | Ný notkun dextransúlfats | |
CA2213481A1 (en) | Compositions and methods for enhancing the growth of hair and restoring hair color | |
SG149002A1 (en) | Hair growth method | |
CA2593923C (fr) | Utilisation d'une base nutritive complexe dans le domaine cosmetique, en particulier capillaire | |
RU2009149607A (ru) | Увлажняющий агент для кожи и его применение | |
CN110652658B (zh) | 使用光和葡糖胺盐酸盐处理皮肤病症的组合物和方法 | |
WO2005034902A1 (ja) | コラーゲン産生促進用組成物 | |
KR102083324B1 (ko) | 동물세포 배양용 무혈청 배지 및 이를 이용한 피부상태 개선용 조성물 | |
CN110292556A (zh) | 间充质干细胞外泌组组合制剂及制备方法和应用 | |
ES2259377T3 (es) | Preparado cosmetico con accion antiarrugas. | |
WO2012057336A1 (ja) | 育毛剤組成物 | |
WO2015036844A1 (en) | Compositions comprising medium supernatant of a stem cell culture | |
JP2005022980A (ja) | 化粧用パックシート及びその製造方法 | |
KR102081974B1 (ko) | 피부 보습 또는 탄력개선용 마스크팩 조성물 | |
RU2805147C2 (ru) | Биологическая добавка для введения в состав косметических и заживляющих средств, способ ее получения, косметические и заживляющие составы на ее основе | |
RU2811487C1 (ru) | Биологическая добавка для введения в состав заживляющих средств, заживляющие составы на ее основе |